These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. H. A. A. and A. N. A. in chronic active hepatitis. Kater L; van den Tweel JG; Lourens J; Borst-Eilers E; Mul NA Lancet; 1971 Mar; 1(7699):598. PubMed ID: 4100932 [No Abstract] [Full Text] [Related]
24. [Study of autoimmune processes by means of the cyclic precipitation reaction in patients with viral hepatitis]. Ishchuk IS Vrach Delo; 1975 Jul; (7):144-5. PubMed ID: 1220217 [No Abstract] [Full Text] [Related]
25. [HB virus antigens in the liver during chronic hepatitis in children]. Alvarez F; Bernard O; Alagille D Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():767-70. PubMed ID: 6762178 [TBL] [Abstract][Full Text] [Related]
26. [HLA antigens in chronic active liver diseases]. Loginov AS; Krel' PE; Fedrunova VS; Pevnitskiĭ LA Ter Arkh; 1981; 53(6):110-3. PubMed ID: 7281021 [No Abstract] [Full Text] [Related]
27. Serum IgE levels in patients with liver disease. Levo Y; Shalit M Ann Allergy; 1981 Dec; 47(6):456-9. PubMed ID: 7325419 [TBL] [Abstract][Full Text] [Related]
28. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
29. Australia antigen in patients with acute and chronic liver disease, in blood donors and recipients. Sanwald R; Sauerbruch T; Lehmann E Vox Sang; 1970; 19(3):412-3. PubMed ID: 5502768 [No Abstract] [Full Text] [Related]
30. Antilactoferrin antibodies in autoimmune liver diseases. Ohana M; Okazaki K; Hajiro K; Uchida K Am J Gastroenterol; 1998 Aug; 93(8):1334-9. PubMed ID: 9707061 [TBL] [Abstract][Full Text] [Related]
31. [Immunochemical and morphological correlations in chronic hepatitis and liver cirrhosis]. Mardare G; Strat C; Drăgan M; Leibovici M; Voiculescu I Med Interna (Bucur); 1970 Apr; 22(4):423-32. PubMed ID: 5419088 [No Abstract] [Full Text] [Related]
32. On the possible role of autoimmunization in liver cirrhosis. Mori W Bull Tokyo Med Dent Univ; 1965 Jun; 12(2):185-97. PubMed ID: 4157520 [No Abstract] [Full Text] [Related]
33. Serum autoantibody against interleukin-1 alpha is unrelated to the etiology or activity of liver disease but can be raised by interferon treatment. Itoh Y; Okanoue T; Sakamoto S; Nishioji K; Kashima K; Ohmoto Y Am J Gastroenterol; 1995 May; 90(5):777-82. PubMed ID: 7733087 [TBL] [Abstract][Full Text] [Related]
35. [Anti-liver antibodies in the course of virus hepatitis and its sequelae]. Kowalczyk M Pol Arch Med Wewn; 1969 Aug; 43(2):1161-7. PubMed ID: 4900787 [No Abstract] [Full Text] [Related]
36. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results]. Kokoreva LN; Zmyzgova AV; Shalygina NB Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646 [TBL] [Abstract][Full Text] [Related]
37. Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases. Frazer IH; Mackay IR Clin Exp Immunol; 1984 Aug; 57(2):429-37. PubMed ID: 6432384 [TBL] [Abstract][Full Text] [Related]
38. [Cellular immunity and chronic liver diseases]. Pipitone V; Numo R; Carrozzo M; De Stasio G Folia Allergol (Roma); 1965; 12(6):450-8. PubMed ID: 5887991 [No Abstract] [Full Text] [Related]
39. Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature. Ramos-Casals M; Pares A; Jara LJ; Solans R; Viñas O; Vázquez P; Sánchez-Tapias JM; Rodés J; Font J; J Viral Hepat; 2005 Nov; 12(6):648-54. PubMed ID: 16255767 [TBL] [Abstract][Full Text] [Related]